Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2023 - 01 - 03 symbols : TMO save search
$1.3 Billion Worldwide Newborn Screening Industry to 2027 - Featuring Agilent Technologies, Baebies, Danaher and Medtronic Among Others
Published: 2023-01-03 (Crawled : 00:00) - prnewswire.com
WAT | $304.18 -3.04% 0.0% 610K
|
Health Technology
|
| O: 0.85%
H: 0.67%
C: 0.36%
TMO | News | $547.25 -1.32% -0.02% 1.6M
|
Health Technology
|
| O: 1.11%
H: 1.52%
C: 0.47%
MDT | News | $79.08 -0.22% 0.0% 5.5M
|
Health Technology
|
| O: 1.12%
H: 3.33%
C: 2.31%
DHR | $239.39 -0.4% 0.03% 2.9M
|
Health Technology
|
| O: 1.12%
H: 1.16%
C: 0.44%
MASI | $136.71 -1.06% -1.08% 220K
|
Health Technology
|
| O: 1.25%
H: 2.49%
C: 2.37%
Global Metabolomics Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts
Published: 2023-01-03 (Crawled : 00:00) - prnewswire.com
WAT | $304.18 -3.04% 0.0% 610K
|
Health Technology
|
| O: 0.85%
H: 0.67%
C: 0.36%
TMO | News | $547.25 -1.32% -0.02% 1.6M
|
Health Technology
|
| O: 1.11%
H: 1.52%
C: 0.47%
DHR | $239.39 -0.4% 0.03% 2.9M
|
Health Technology
|
| O: 1.12%
H: 1.16%
C: 0.44%
BRKR | News | $82.97 -1.1% -1.11% 690K
|
Health Technology
|
| O: 1.46%
H: 0.51%
C: 0.16%
global report market
Worldwide Diagnostics Industry to 2030 - Increase in Prevalence of Chronic & Infectious Diseases and Availability of Point-Of-Care Testing Kits Drives Growth
Published: 2023-01-03 (Crawled : 22:00) - prnewswire.com
TMO | News | $547.25 -1.32% -0.02% 1.6M
|
Health Technology
|
| O: 1.11%
H: 1.52%
C: 0.47%
BDX | $232.21 0.52% -0.52% 1.5M
|
Health Technology
|
| O: 0.71%
H: 0.2%
C: 0.03%
ABT | News | $105.9 -3.03% 0.07% 12M
|
Health Technology
|
| O: 1.3%
H: 0.84%
C: 0.18%
diagnostics growth
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, February 1, 2023
Published: 2023-01-03 (Crawled : 14:00) - biospace.com/
TMO | News | $547.25 -1.32% -0.02% 1.6M
|
Health Technology
|
| O: 0.47%
H: 0.51%
C: -0.02%
conference
ASLAN Pharmaceuticals and Thermo Fisher Scientific Announce Partnership to Manufacture High Concentration Formulation of Eblasakimab for Future Studies
Published: 2023-01-03 (Crawled : 14:00) - biospace.com/
TMO | News | $547.25 -1.32% -0.02% 1.6M
|
Health Technology
|
| O: 0.47%
H: 0.51%
C: -0.02%
ASLN | $0.4917 0.0% 150K
|
Health Technology
|
| O: 7.78%
H: 14.43%
C: 12.15%
partnership pharmaceuticals
Thermo Fisher Scientific Completes Acquisition of The Binding Site Group
Published: 2023-01-03 (Crawled : 13:00) - biospace.com/
TMO | News | $547.25 -1.32% -0.02% 1.6M
|
Health Technology
|
| O: 0.47%
H: 0.51%
C: -0.02%
acquisition group
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.